Yee Chao Selected Research

3,3'-diethyloxadicarbocyanine

1/2004

A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yee Chao Research Topics

Disease

78	Neoplasms (Cancer) 04/2022 - 05/2003
53	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 05/2003
26	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2002
16	Adenocarcinoma 01/2022 - 08/2005
9	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2003
8	Disease Progression 04/2022 - 05/2012
8	Carcinoma (Carcinomatosis) 01/2022 - 09/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2002
7	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 03/2011
7	Fever (Fevers) 01/2016 - 03/2005
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2007
6	Neutropenia 01/2018 - 09/2003
5	Gastric Outlet Obstruction 01/2022 - 12/2012
5	Fibrosis (Cirrhosis) 01/2022 - 01/2016
5	Carcinogenesis 05/2020 - 01/2013
4	Fatigue 01/2016 - 03/2005
3	Microsatellite Instability 01/2022 - 12/2019
3	Rectal Neoplasms (Rectal Cancer) 06/2021 - 03/2005
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 12/2003
3	Nausea 05/2018 - 09/2003
3	Vomiting 05/2018 - 09/2003
3	Diarrhea 05/2018 - 03/2013
3	Hypertension (High Blood Pressure) 01/2018 - 10/2013
3	Cholangiocarcinoma 03/2017 - 01/2013
3	Inflammation (Inflammations) 01/2016 - 09/2005
3	Leukemia 03/2012 - 01/2004
2	Brain Stem Neoplasms (Brain Stem Tumor) 04/2022 - 02/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 09/2004
2	Duodenal Obstruction 01/2022 - 01/2020
2	Brain Neoplasms (Brain Tumor) 04/2021 - 06/2020
2	Hepatitis B 02/2021 - 08/2007
2	Infections 06/2020 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 05/2020 - 09/2015
2	Sarcoma (Soft Tissue Sarcoma) 08/2019 - 01/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2019 - 09/2018
2	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 01/2006
2	Exanthema (Rash) 05/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

19	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 03/2013
15	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 07/2002
11	NivolumabIBA 01/2022 - 12/2017
11	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 07/2002
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2019
10	Gemcitabine FDA Link 01/2022 - 09/2003
8	Leucovorin (Folinic Acid)FDA Link 01/2022 - 07/2002
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 12/2009
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2007
6	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
6	BilirubinIBA 01/2022 - 01/2018
6	AlbuminsIBA 01/2022 - 01/2018
6	pembrolizumabIBA 06/2021 - 04/2017
6	Docetaxel (Taxotere)FDA Link 01/2016 - 08/2005
6	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 01/2008
5	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 12/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 05/2003
4	regorafenibIBA 04/2022 - 01/2020
4	CytokinesIBA 08/2021 - 09/2005
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2012
4	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 12/2012
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 12/2018
3	B7-H1 AntigenIBA 01/2022 - 06/2020
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2017
3	AntigensIBA 02/2020 - 03/2017
3	PlatinumIBA 01/2020 - 01/2016
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 12/2014
3	Phosphotransferases (Kinase)IBA 08/2019 - 03/2012
3	Serum AlbuminIBA 12/2018 - 12/2014
3	RamucirumabIBA 04/2018 - 03/2016
3	Capecitabine (Xeloda)FDA Link 01/2017 - 04/2014
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2016 - 10/2013
3	TegafurIBA 06/2011 - 03/2005
3	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 07/2002
2	LigandsIBA 01/2022 - 01/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 03/2011
2	tislelizumabIBA 01/2022 - 01/2020
2	ProdrugsIBA 12/2021 - 06/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 05/2013
2	CreatinineIBA 02/2021 - 12/2018
2	AntibodiesIBA 02/2021 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2019
2	CarbohydratesIBA 02/2020 - 03/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 12/2016
2	Monoclonal AntibodiesIBA 01/2020 - 12/2017
2	Aurora Kinase AIBA 10/2019 - 09/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2019 - 12/2003
2	Carcinoembryonic AntigenIBA 07/2018 - 03/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 03/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 05/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 05/2012

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 04/2022 - 07/2002
36	Therapeutics 04/2022 - 07/2002
10	Radiotherapy 04/2022 - 03/2005
6	Immunotherapy 01/2022 - 03/2005
5	Stents 01/2022 - 12/2012
5	Gastrectomy 11/2021 - 08/2011
4	Self Expandable Metallic Stents 01/2022 - 07/2015
4	Chemoradiotherapy 01/2015 - 09/2003
3	Boron Neutron Capture Therapy 04/2022 - 06/2020
2	Salvage Therapy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 01/2018